期刊文献+
共找到713篇文章
< 1 2 36 >
每页显示 20 50 100
Clinical Analysis of Early Application of Bi-level Positive Airway Pressure ventilation in the Treatment of COPD with Type II Respiratory Failure
1
作者 Yanbing Wang 《Journal of Clinical and Nursing Research》 2019年第3期16-18,共3页
Objective:To analyze the clinical efficacy of early application of bi-level positive airway pressure ventilation in the treatment of COPD with type II respiratory failure.Method:A total of 58 patients with COPD and ty... Objective:To analyze the clinical efficacy of early application of bi-level positive airway pressure ventilation in the treatment of COPD with type II respiratory failure.Method:A total of 58 patients with COPD and type II respiratory failure admitted to our hospital from January 2017 to January 2019 were randomly divided into observation group and control group,with 29 cases in each group.Among them,the control group was received routine treatment while the observation group was treated with bi-level positive pressure airway ventilation in addition of conventional treatment.The arterial blood gas analysis,mortality rate and hospitalization time of these two groups before and after treatment were compared.Result:The blood pH,partial pressure of oxygen(PaO2)and arterial oxygen saturation(SaO2)of these two groups were significantly higher after the treatment while PaO2 alone was decreased.The difference was statistically significant(P<0.05).The results of arterial blood gas analysis in the observation group were significantly improved compared with those before treatment.The mortality rate and hospitalization time were significantly less than the control group,and the difference was statistically significant(P<0.05).Conclusion:Early clinical application of bi-level positive airway pressure ventilation in the treatment of COPD with type II respiratory failure has a significant clinical effect in reducing the mortality rate and hospitalization time of patients,and thus it is worthy of clinical application. 展开更多
关键词 bi-level positive AIRWAY pressure ventilation copd type II respiratory failure EFFICACY
下载PDF
Driving pressure in mechanical ventilation:A review 被引量:2
2
作者 Syeda Farheen Zaidi Asim Shaikh +2 位作者 Daniyal Aziz Khan Salim Surani Iqbal Ratnani 《World Journal of Critical Care Medicine》 2024年第1期15-27,共13页
Driving pressure(ΔP)is a core therapeutic component of mechanical ventilation(MV).Varying levels ofΔP have been employed during MV depending on the type of underlying pathology and severity of injury.However,ΔP lev... Driving pressure(ΔP)is a core therapeutic component of mechanical ventilation(MV).Varying levels ofΔP have been employed during MV depending on the type of underlying pathology and severity of injury.However,ΔP levels have also been shown to closely impact hard endpoints such as mortality.Considering this,conducting an in-depth review ofΔP as a unique,outcome-impacting therapeutic modality is extremely important.There is a need to understand the subtleties involved in making sureΔP levels are optimized to enhance outcomes and minimize harm.We performed this narrative review to further explore the various uses ofΔP,the different parameters that can affect its use,and how outcomes vary in different patient populations at different pressure levels.To better utilizeΔP in MV-requiring patients,additional large-scale clinical studies are needed. 展开更多
关键词 Driving pressure acute respiratory distress syndrome MORTALITY positive end-expiratory pressure Ventilator induced lung injury Mechanical ventilation
下载PDF
Effect of protective lung ventilation strategy combined with lung recruitment maneuver in patients with acute respiratory distress syndrome (ARDS) 被引量:2
3
作者 Sheng Yu Tian-Xiao Hu +1 位作者 Jun Jin Sheng Zhang 《Journal of Acute Disease》 2017年第4期163-168,共6页
Objective:To evaluate the efficacy and safety of protective lung ventilation strategy combined with lung recruitment maneuver (RM) in the treatment patients with acute respiratory distress syndrome (ARDS).Methods:Tota... Objective:To evaluate the efficacy and safety of protective lung ventilation strategy combined with lung recruitment maneuver (RM) in the treatment patients with acute respiratory distress syndrome (ARDS).Methods:Totally 74 patients with ARDS admitted to the Department of Intensive Care Unit, Changshu Second People's Hospital in Jiangsu Province between September 2010 and June 2013 were selected and randomly divided into lung recruitment group and non-lung recruitment group, and the initial ventilation solution for both groups was synchronized intermittent mandatory ventilation (SIMV). For RM, SIMV mode (pressure control and pressure support) was adopted. Positive end expiratory pressure (PEEP) was increased by 5 cm H2O every time and maintained for 40-50 s before entering the next increasing period, and the peak airway pressure was kept below 45 cm H2O. After PEEP reached the maximum value, it was gradually reduced by 5 cm H2O every time and finally maintained at 15 cm H2O for 10 min.Results:A total of 74 patients with mean age of (49.0±18.6) years old were enrolled, 36 patients were enrolled in lung recruitment maneuver (RM) group and 38 patients were enrolled into non-lung recruitment maneuver (non-RM) group. 44 were male and accounted for 59.5% of all the patients. For the indicators such as PEEP, pressure support (PS), plateau airway pressure (Pplat), peak airway pressure (Ppeak), vital capacity (VC) and fraction of inspired oxygen (FiO2), no statistical differences in the indicators were found between the RM group and non-RM group on D1, D3 and D7 (P>0.05), except that only FiO2 of RM group on D7 was significantly lower than that of non-RM group (47.2±10.0) vs. (52.2±10.5),P<0.05]. For the indicators of blood gas analysis, including pH, arterial oxygen pressure (PaO2), arterial carbon dioxide pressure (PaCO2) and oxygenation index (PaO2/FiO2), PaO2 and PaO2/FiO2 of RM group were significantly higher than those of non-RM group on D7, and the values were [(90.2±16.1) mmHg vs. (76.4±11.3) mmHg,P<0.05] and [(196.5±40.7) mmHg vs. (151.7±37.3) mmHg,P<0.05] respectively. There was no statistical difference in heart rate (HR), cardiac index (CI), central venous pressure (CVP) or mean arterial pressure (MAP) between RM group and non-RM group on D1, D3 and D7 (P>0.05). 28-day mortality, ICU mortality and in-hospital mortality were 25% vs. 28.9%, 25% vs. 26.3% and 36.1% vs. 39.5% respectively between RM group and non-RM group (allP>0.05).Conclusion:Protective lung ventilation strategy combined with lung recruitment maneuver can improve the indicators such as PaO2, FiO2 and PaO2/FiO2 on D7, but failed to improve the final outcomes such as 28-day mortality, ICU mortality and in-hospital mortality. 展开更多
关键词 acute respiratory DISTRESS syndrome LUNG RECRUITMENT MANEUVER Mechanical ventilation positive end expiratory pressure
下载PDF
HFNC与NIPPV对AECOPD合并Ⅱ型呼吸衰竭患者的临床疗效观察
4
作者 应琴丽 周世彬 +3 位作者 李焕根 魏思灿 黄鸣恋 陈伟文 《北京医学》 CAS 2024年第3期204-209,共6页
目的探讨经鼻高流量氧疗(high-flow nasal cannula,HFNC)与无创正压通气(non-invasive positive pressure ventilation,NIPPV)对慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)合并... 目的探讨经鼻高流量氧疗(high-flow nasal cannula,HFNC)与无创正压通气(non-invasive positive pressure ventilation,NIPPV)对慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)合并Ⅱ型呼吸衰竭患者的临床疗效。方法选取2021年1月至2023年1月福建医科大学附属泉州第一医院重症医学科AECOPD患者146例,根据治疗方法不同分为NIPPV组(n=47)、HFNC组(n=49)和常规治疗组(n=50)。NIPPV组采用NIPPV治疗,HFNC组采用HFNC治疗,常规治疗组采用常规氧疗和抗感染治疗。比较3组循环指标、血气指标、呼吸支持时间、气道护理次数及舒适(general comfort questionnaire,GCQ)评分。结果146例患者中男76例、女70例,年龄56~77岁,平均(66.2±5.3)岁。与治疗前相比,治疗2 h和治疗24 h时,3组呼吸频率(respiratory rate,RR)和HR较低;治疗6 h和治疗24 h时,HFNC组RR、HR均低于NIPPV组和常规治疗组,差异有统计学意义(P<0.05)。与治疗前相比,治疗7 d后3组PaO_(2)均升高、PaCO_(2)均降低;治疗7 d后,与NIPPV组和常规组相比,HFNC组PaO_(2)较高、PaCO_(2)较低,差异有统计学意义(P<0.05)。3组呼吸支持时间和气道护理次数的差异有统计学意义(P<0.05),其中NIPPV组呼吸支持时间较短,HFNC组气道护理次数较少。结论HFNC可以改善AECOPD合并Ⅱ型呼衰患者的部分循环指标和血气指标,患者舒适度更好,但呼吸支持时间较长。 展开更多
关键词 慢性阻塞性肺疾病急性加重期 呼吸衰竭 经鼻高流量氧疗 无创正压通气
下载PDF
Clinical characteristics and outcomes associated with nasal intermittent mandatory ventilation in acute pediatric respiratory failure 被引量:1
5
作者 Billy C Wang Theodore Pei +4 位作者 Cheryl B Lin Rong Guo David Elashoff James A Lin Carol Pineda 《World Journal of Critical Care Medicine》 2018年第4期46-51,共6页
AIM To characterize the clinical course and outcomes of nasal intermittent mandatory ventilation(NIMV) use in acute pediatric respiratory failure.METHODS We identified all patients treated with NIMV in the pediatric i... AIM To characterize the clinical course and outcomes of nasal intermittent mandatory ventilation(NIMV) use in acute pediatric respiratory failure.METHODS We identified all patients treated with NIMV in the pediatric intensive care unit(PICU) or inpatient general pediatrics between January 2013 and December 2015 at two academic centers.Patients who utilized NIMV with other modes of noninvasive ventilation during the same admission were included.Data included demographics,vital signs on admission and prior to initiation of NIMV,pediatric risk of mortality Ⅲ(PRIsM-Ⅲ) scores,complications,respiratory support characteristics,PICU and hospital length of stays,duration of respiratory support,and complications.Patients who did not require escalation to mechanical ventilation were defined as NIMV responders;those who required escalation to mechanical ventilation(MV) were defined as NIMV nonresponders.NIMV responders were compared to NIMV non-responders.RESULTS Forty-two patients met study criteria.six(14%) failed treatment and required MV.The majority of the patients(74%) had a primary diagnosis of bronchiolitis.The median age of these 42 patients was 4 mo(range 0.5-28.1 mo,IQR 7,P = 0.69).No significant difference was measured in other baseline demographics and vitals on initiation of NIMV;these included age,temperature,respiratory rate,O2 saturation,heart rate,systolic blood pressure,diastolic blood pressure,and PRIsM-Ⅲ scores.The duration of NIMV was shorter in the NIMV nonresponder vs NIMV responder group(6.5 h vs 65 h,P < 0.0005).Otherwise,NIMV failure was not associated with significant differences in PICU length of stay(LOs),hospital LOs,or total duration of respiratory support.No patients had aspiration pneumonia,pneumothorax,or skin breakdown.CONCLUSION Most of our patients responded to NIMV.NIMV failure is not associated with differences in hospital LOs,PICU LOs,or duration of respiratory support. 展开更多
关键词 Continuous positive AIRWAY pressure Pediatric Noninvasive positive pressure ventilation NASAL INTERMITTENT MANDATORY ventilation High flow NASAL cannula acute respiratory failure Bilevel positive AIRWAY pressure
下载PDF
无创正压机械通气治疗AECOPD合并呼吸衰竭的效果
6
作者 刘成林 刘海洋 《中国卫生标准管理》 2024年第14期92-95,共4页
目的对比慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)合并呼吸衰竭(respiratory failure,RF)患者应用无创正压机械通气(noninvasive positive pressure ventilation,NPPV)与常规... 目的对比慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)合并呼吸衰竭(respiratory failure,RF)患者应用无创正压机械通气(noninvasive positive pressure ventilation,NPPV)与常规对症治疗在治疗效果之间的差异及2种治疗方式对血气指标、肺相关功能的影响。方法回顾性分析东台市人民医院2021年1月—2023年6月收治的82例AECOPD合并RF患者。按照治疗方法的差异分为常规组、NPPV组,各41例。对比2组患者肺功能情况、血气指标、生命体征指标、临床疗效和不良反应发生情况。结果NPPV组治疗后用力肺活量(forced vital capacity,FVC)、第1秒用力呼气容积(forced expiratory volume in the first second,FEV_(1))、第1秒用力呼气容积占用力肺活量的比例(forced expiratory volume in the first second/forced vital capacity,FEV_(1)/FVC)、动脉血氧分压(partial pressure of oxygen in arterial blood,PaO_(2))高于常规组,而动脉血二氧化碳分压(partial pressure of carbon dioxide in arterial blood,PaCO_(2))低于常规组(P<0.05);NPPV组治疗后的呼吸频率、心率、平均动脉压均低于常规组(P<0.05);NPPV组总有效率为95.12%,高于常规组的73.17%(P<0.05);NPPV组不良反应总发生率为7.32%,低于常规组的26.83%(P<0.05)。结论NPPV治疗能够让AECOPD合并RF患者的肺功能得以提高,临床治疗效果较好,改善其血氧方面的指标及预后。 展开更多
关键词 无创正压机械通气 呼吸衰竭 肺功能 血气指标 慢性阻塞性肺疾病急性加重期 疗效
下载PDF
BiPAP无创呼吸机联合噻托溴铵对AECOPD伴呼吸衰竭患者呼吸强度及肺功能的影响
7
作者 周春晴 邹汶 杨哲 《中国医学创新》 CAS 2024年第12期26-30,共5页
目的:探究双水平气道正压通气(BiPAP)无创呼吸机联合噻托溴铵对急性加重期慢性阻塞性肺疾病(AECOPD)伴呼吸衰竭(呼衰)患者呼吸强度及肺功能的影响。方法:选取2020年10月—2022年9月瑞金市人民医院急诊科收治的AECOPD伴呼衰患者68例,随... 目的:探究双水平气道正压通气(BiPAP)无创呼吸机联合噻托溴铵对急性加重期慢性阻塞性肺疾病(AECOPD)伴呼吸衰竭(呼衰)患者呼吸强度及肺功能的影响。方法:选取2020年10月—2022年9月瑞金市人民医院急诊科收治的AECOPD伴呼衰患者68例,随机分为对照组和观察组,各34例。对照组予以单独Bi PAP无创呼吸机治疗,观察组在对照组的基础上加用噻托溴铵,均治疗10 d。评价两组的治疗效果及不良反应发生情况,比较两组治疗前、治疗10 d后血气、呼吸动力学及肺功能指标。结果:观察组治疗总有效率高于对照组,差异有统计学意义(88.24%vs 67.65%)(P<0.05)。治疗10 d后,观察组动脉血氧分压(PaO_(2))、氧合指标(PaO_(2)/FiO_(2))、动脉血氧饱和度(SaO_(2))、吸气峰值压(PIP)、第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、最高呼气流速(PEF)及最大呼气中段流量(MMEF)均高于对照组,其动脉血二氧化碳分压(PaCO_(2))、平台压(Pplat)、平均气道压(MPaw)及气道阻力(Raw)均低于对照组,差异均有统计学意义(P<0.05)。对照组和观察组不良反应发生率分别为5.88%和11.76%,差异无统计学意义(P>0.05)。结论:BiPAP无创呼吸机联合噻托溴铵治疗可有效改善AECOPD伴呼衰患者呼吸强度,且能够改善患者肺功能,调节血氧水平,有效且安全。 展开更多
关键词 慢性阻塞性肺疾病急性加重期 呼吸衰竭 双水平气道正压通气 无创呼吸机 噻托溴铵
下载PDF
无创正压通气联合氧气驱动雾化吸入对COPD合并呼吸衰竭患者的有效性和安全性分析
8
作者 申国庆 甘文云 +2 位作者 刘辉 索美芳 王运 《临床研究》 2024年第7期85-88,共4页
目的探究无创正压通气(NPPV)联合氧气驱动雾化吸入对慢性阻塞性肺疾病(COPD)合并呼吸衰竭患者的有效性和安全性。方法选取2021年2月至2023年2月期间驻马店市中心医院收治的94例COPD合并呼吸衰竭患者,应用随机数表法将其分为对照组(n=47... 目的探究无创正压通气(NPPV)联合氧气驱动雾化吸入对慢性阻塞性肺疾病(COPD)合并呼吸衰竭患者的有效性和安全性。方法选取2021年2月至2023年2月期间驻马店市中心医院收治的94例COPD合并呼吸衰竭患者,应用随机数表法将其分为对照组(n=47)及观察组(n=47),对照组接受NPPV治疗,观察组联合氧气驱动雾化吸入治疗,对比两组治疗有效率、血气指标、肺功能指标、炎症因子水平、圣乔治呼吸量表评分(SGRQ)。结果观察组治疗有效率高于对照组,差异具有统计学意义(P<0.05)。观察组PaO_(2)、pH水平高于对照组,PaCO_(2)水平低于对照组,差异有统计学意义。观察组用力肺活量(FVC)、第一秒用力呼气容积(FEV_(1))、一秒钟用力呼气容积与用力肺活量的比值(FEV_(1)/FVC)水平高于对照组,差异具有统计学意义(P<0.05)。观察组C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-8(IL-8)水平低于对照组,差异具有统计学意义(P<0.05)。观察组各维度呼吸问题评分低于对照组,差异具有统计学意义(P<0.05)。结论COPD合并呼吸衰竭患者采用NPPV联合氧气驱动雾化吸入治疗效果显著,可改善血气指标,改善肺功能,降低炎症因子水平,可改善呼吸衰竭患者呼吸相关问题。 展开更多
关键词 无创正压通气 氧气驱动雾化吸入 copd 呼吸衰竭 有效性 安全性
下载PDF
Recruitment maneuvers in acute respiratory distress syndrome: The safe way is the best way 被引量:19
9
作者 Raquel S Santos Pedro L Silva +1 位作者 Paolo Pelosi Patricia RM Rocco 《World Journal of Critical Care Medicine》 2015年第4期278-286,共9页
Acute respiratory distress syndrome(ARDS) represents a serious problem in critically ill patients and is associated with in-hospital mortality rates of 33%-52%. Recruitment maneuvers(RMs) are a simple, low-cost, feasi... Acute respiratory distress syndrome(ARDS) represents a serious problem in critically ill patients and is associated with in-hospital mortality rates of 33%-52%. Recruitment maneuvers(RMs) are a simple, low-cost, feasible intervention that can be performed at the bedside in patients with ARDS. RMs are characterized by the application of airway pressure to increase transpulmonary pressure transiently. Once non-aerated lung units are reopened, improvements are observed in respiratory system mechanics, alveolar reaeration on computed tomography, and improvements in gas exchange(functional recruitment). However, the reopening process could lead to vascular compression, which can be associated with overinflation, and gas exchange may not improve as expected(anatomical recruitment). The purpose of this review was to discuss the effects of different RM strategies- sustained inflation, intermittent sighs, and stepwise increases of positive end-expiratory pressure(PEEP) and/or airway inspiratory pressure- on the following parameters: hemodynamics, oxygenation, barotrauma episodes, and lung recruitability through physiological variables and imaging techniques. RMs and PEEP titration are interdependent events for the success of ventilatory management. PEEP should be adjusted on the basis of respiratory system mechanics and oxygenation. Recent systematic reviews and meta-analyses suggest that RMs are associated with lower mortality in patients with ARDS. However, the optimal RM method(i.e., that providing the best balance of benefit and harm) and the effects of RMs on clinical outcome are still under discussion, and further evidence is needed. 展开更多
关键词 RECRUITMENT MANEUVERS acute respiratory DISTRESS syndrome positive end-expiratory pressure Transpulmonary pressure Lung ULTRASONOGRAPHY
下载PDF
肠内-肠外联合营养与双水平气道正压通气对COPD急性加重期合并Ⅱ型呼吸衰竭患者的应用效果 被引量:5
10
作者 刘小珊 谢芳 +1 位作者 郝小丹 王璋 《贵州医科大学学报》 CAS 2023年第3期347-351,372,共6页
目的探讨肠内-肠外联合营养与双水平气道正压通气(BiPAP)对慢性阻塞性肺疾病(COPD)急性加重期(AECOPD)合并Ⅱ型呼吸衰竭患者的应用效果。方法136例AECOPD合并Ⅱ型呼吸衰竭患者均分为联合组和对照组,2组均接受BiPAP治疗,对照组给予肠内... 目的探讨肠内-肠外联合营养与双水平气道正压通气(BiPAP)对慢性阻塞性肺疾病(COPD)急性加重期(AECOPD)合并Ⅱ型呼吸衰竭患者的应用效果。方法136例AECOPD合并Ⅱ型呼吸衰竭患者均分为联合组和对照组,2组均接受BiPAP治疗,对照组给予肠内营养支持,联合组加用肠内-肠外联合营养支持,持续7 d;比较2组患者临床预后,比较2组患者治疗前、治疗10 d时的营养指标[前白蛋白(PA)、白蛋白(ALB)、总蛋白(TP)]、血气分析指标[血氧饱和度(SaO_(2))、动脉血血氧分压(PaO_(2))、动脉血二氧化碳分压(PaCO_(2))、酸碱度(pH)]及肺功能指标[第1秒用力呼出气体总量(FEV1)、尽力吸气呼气最大气量(FVC)及最大的呼气流量(PEF)]变化。结果联合组AECOPD患者BiPAP通气时间、ICU住院时间、总住院时间低于对照组(P<0.05),2组AECOPD合并Ⅱ型呼吸衰竭患者28 d病死率、胃肠不耐受发生率比较,差异无统计学意义(P>0.05);治疗10 d时,2组患者PA、ALB、TP,SaO_(2)、PaO_(2)、pH及FEV1、FVC、PEF均较治疗前升高,联合组患者的PA、ALB、TP及FEV1、FVC、PEF均高于对照组,PaCO_(2)低于对照组,差异有统计学意义(P<0.05)。结论在BiPAP的基础上给予肠内-肠外联合营养有利于促进AECOPD合并Ⅱ型呼吸衰竭患者营养状态、血气指标及肺功能恢复。 展开更多
关键词 肠内-肠外联合营养 双水平气道正压通气 慢性阻塞性肺疾病 呼吸衰竭
下载PDF
Role of proning and positive end-expiratory pressure in COVID-19
11
作者 Kejal D Gandhi Munish Sharma +1 位作者 Pahnwat Tonya Taweesedt Salim Surani 《World Journal of Critical Care Medicine》 2021年第5期183-193,共11页
The novel coronavirus,which was declared a pandemic by the World Health Organization in early 2020 has brought with itself major morbidity and mortality.It has increased hospital occupancy,heralded economic turmoil,an... The novel coronavirus,which was declared a pandemic by the World Health Organization in early 2020 has brought with itself major morbidity and mortality.It has increased hospital occupancy,heralded economic turmoil,and the rapid transmission and community spread have added to the burden of the virus.Most of the patients are admitted to the intensive care unit(ICU)for acute hypoxic respiratory failure often secondary to acute respiratory distress syndrome(ARDS).Based on the limited data available,there have been different opinions about the respiratory mechanics of the ARDS caused by coronavirus disease 2019(COVID-19).Our article provides an insight into COVID-19 pathophysiology and how it differs from typical ARDS.Based on these differences,our article explains the different approach to ventilation in COVID-19 ARDS compared to typical ARDS.We critically analyze the role of positive end-expiratory pressure(PEEP)and proning in the ICU patients.Through the limited data and clinical experience are available,we believe that early proning in COVID-19 patients improves oxygenation and optimal PEEP should be titrated based on individual lung compliance. 展开更多
关键词 COVID-19 acute respiratory distress syndrome positive end-expiratory pressure Proning Ventilation management acute respiratory distress syndrome Intensive care unit
下载PDF
无创正压通气联合纳洛酮治疗AECOPD并发呼吸衰竭患者的临床疗效 被引量:3
12
作者 黄兴伟 叶开颂 杨瑞党 《临床合理用药杂志》 2023年第3期1-4,共4页
目的 探讨无创正压通气(NPPV)联合纳洛酮治疗慢性阻塞性肺疾病急性加重期(AECOPD)并发呼吸衰竭患者的临床疗效。方法 回顾性选取2017年1月—2022年4月福建医科大学附属闽东医院收治的70例AECOPD并发呼吸衰竭患者作为研究对象,根据不同... 目的 探讨无创正压通气(NPPV)联合纳洛酮治疗慢性阻塞性肺疾病急性加重期(AECOPD)并发呼吸衰竭患者的临床疗效。方法 回顾性选取2017年1月—2022年4月福建医科大学附属闽东医院收治的70例AECOPD并发呼吸衰竭患者作为研究对象,根据不同的治疗方式分为对照组33例和观察组37例。患者均接受常规治疗,在此基础上,对照组患者接受无创正压通气(NPPV)治疗,观察组在对照组基础上加用盐酸纳洛酮注射液治疗。2组均治疗1周。比较2组治疗前及治疗1周后生命体征指标[脉搏、收缩压(SBP)、舒张压(DBP)、呼吸频率]、血气分析指标[血氧饱和度(SpO_(2))、动脉血二氧化碳分压(Pa CO_(2))、动脉血氧分压(PaO_(2))]、肺功能指标[第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)及呼气峰值流速(PEF)]、生活质量评分及不良反应发生率。结果 治疗1周后,2组脉搏、SBP、DBP、呼吸频率及Pa CO_(2)均较治疗前降低,SpO_(2)、PaO_(2)均较治疗前升高,且观察组Pa CO_(2)均较对照组更低,SpO_(2)、PaO_(2)较对照组更高(P<0.01)。治疗1周后,2组FEV_(1)、FVC、PEF及躯体、认知、情绪、角色、社会功能、总体健康评分均较治疗前升高,且观察组较对照组更高(P<0.01)。治疗期间,观察组不良反应总发生率为8.11%,与对照组的15.15%比较,差异无统计学意义(χ^(2)=0.855,P=0.462)。结论 NPPV联合纳洛酮治疗AECOPD并发呼吸衰竭可更有效地改善患者血气及肺功能,提高生活质量,且安全性较高。 展开更多
关键词 慢性阻塞性肺疾病 急性加重期 呼吸衰竭 无创正压通气 纳洛酮 血气分析 肺功能
下载PDF
经鼻高流量湿化氧疗与无创正压通气在AECOPD合并急性呼吸衰竭治疗中的效果对比研究 被引量:2
13
作者 林秋劲 方文西 《中外医学研究》 2023年第28期35-38,共4页
目的:比较慢性阻塞性肺疾病急性加重期(AECOPD)合并急性呼吸衰竭患者采用经鼻高流量湿化氧疗(HFNC)与无创正压通气(NPPV)治疗的临床效果。方法:选择2021年1月—2023年5月海丰县彭湃纪念医院收治的141例AECOPD合并急性呼吸衰竭患者作为... 目的:比较慢性阻塞性肺疾病急性加重期(AECOPD)合并急性呼吸衰竭患者采用经鼻高流量湿化氧疗(HFNC)与无创正压通气(NPPV)治疗的临床效果。方法:选择2021年1月—2023年5月海丰县彭湃纪念医院收治的141例AECOPD合并急性呼吸衰竭患者作为研究对象,采用随机数表法将患者分为A组、B组和C组,各47例。A组仅接受常规治疗,B组在常规治疗基础上接受HFNC治疗,C组在常规治疗基础上接受NPPV治疗。比较三组心率(HR)、呼吸频率(RR)、平均动脉压(MAP)、血气分析指标[动脉血氧分压(PaO_(2))、二氧化碳分压(PaCO_(2))及pH值]、炎症指标[白细胞计数(WBC)、C反应蛋白(CRP)及血清降钙素原(PCT)]及并发症发生情况。结果:治疗后,三组HR、RR、PaCO_(2)、WBC、CRP及PCT低于治疗前,MAP、PaO_(2)、pH值高于治疗前,差异有统计学意义(P<0.05);且B组、C组治疗后HR、RR、PaCO_(2)、WBC、CRP及PCT低于A组,MAP、PaO_(2)、pH值高于A组,差异有统计学意义(P<0.05);但B组、C组治疗后各指标比较,差异无统计学意义(P>0.05)。B组并发症发生率低于C组,差异有统计学意义(P<0.05)。结论:AECOPD合并急性呼吸衰竭采用HFNC与NPPV治疗,其临床疗效良好且相当,但HFNC可有效控制并发症发生率,安全性较高。 展开更多
关键词 慢性阻塞性肺疾病加重期 急性呼吸衰竭 高流量湿化氧疗 无创正压通气 并发症
下载PDF
无创正压通气与经鼻导管持续低流量吸氧治疗老年AECOPD合并呼吸衰竭患者的效果比较 被引量:2
14
作者 代煜 《中国民康医学》 2023年第2期167-170,共4页
目的:比较无创正压通气(NPPV)与经鼻导管持续低流量吸氧治疗老年慢性阻塞性肺疾病急性加重(AECOPD)合并呼吸衰竭患者的效果。方法:选取2018年2月至2021年10月该院收治的84例老年AECOPD合并呼吸衰竭患者进行前瞻性研究。按随机数字法将... 目的:比较无创正压通气(NPPV)与经鼻导管持续低流量吸氧治疗老年慢性阻塞性肺疾病急性加重(AECOPD)合并呼吸衰竭患者的效果。方法:选取2018年2月至2021年10月该院收治的84例老年AECOPD合并呼吸衰竭患者进行前瞻性研究。按随机数字法将其分成观察组及对照组各42例。对照组给予经鼻导管持续低流量吸氧治疗,观察组采用NPPV治疗。比较两组康复时间,治疗前后动脉血气指标[动脉血氧分压(PaO2)、二氧化碳分压(PaCO_(2))及pH值]水平、肺通气功能指标[第1秒用力呼气容积(FEV1)和FEV1/用力肺活量(FVC)]水平及血清肺损伤指标[Clard细胞分泌蛋白(CC16)、巨噬细胞刺激蛋白(MSP)]水平。结果:观察组发绀、气促、胸闷症状消失时间,通气时间及ICU住院时间均短于对照组,治疗后PaO2水平、pH值、FEV1、FEV1/FVC、CC16水平均高于对照组,PaCO_(2)、MSP水平均低于对照组,差异有统计学意义(P<0.05)。结论:NPPV用于老年AECOPD合并呼吸衰竭患者可加快症状缓解,促进患者动脉血气指标、肺通气功能指标改善,缩短通气治疗时间和住院时间,还可减轻肺部炎症,效果优于常规经鼻导管持续低流量吸氧。 展开更多
关键词 无创正压通气 慢性阻塞性肺疾病 急性加重 呼吸衰竭 血气指标 老年
下载PDF
无创正压通气治疗COPD急性加重合并重度Ⅱ型呼吸衰竭的效果分析 被引量:1
15
作者 包蒙 《智慧健康》 2023年第2期71-74,共4页
目的 在COPD急性加重合并重度Ⅱ型呼吸衰竭治疗中,采用不同治疗方案,总结与探究无创正压通气治疗方案实施效果。方法 于2015年1月-2020年12月共纳入38例因COPD急性加重合并重度Ⅱ型呼吸衰竭而就诊于本科室接受无创正压通气治疗的病人进... 目的 在COPD急性加重合并重度Ⅱ型呼吸衰竭治疗中,采用不同治疗方案,总结与探究无创正压通气治疗方案实施效果。方法 于2015年1月-2020年12月共纳入38例因COPD急性加重合并重度Ⅱ型呼吸衰竭而就诊于本科室接受无创正压通气治疗的病人进行调研,将其作为本次调研的研究组。选择同期就诊于本科室的COPD急性加重合并重度Ⅱ型呼吸衰竭病人但未接受无创正压通气治疗的38例病人进行对照,将其作为本次调研的对照组。总结与探究对照组、研究组治疗方案实施效果。结果 对照组与研究组病人住院时间对照,对照组住院时间较长,两组差异明显(P<0.05)。治疗前对照组与研究组pH值对照无差异,PaCO_(2)指标、PaO_(2)指标水平对照无差异(P>0.05),治疗后两组病人指标水平明显改善,但研究组与对照组病人PaO_(2)指标水平相比较高,PaCO_(2)指标水平相比较低,pH值相比较高,两组差异明显(P<0.05)。研究组参与调研的38例病人中,有4例病人发生了不良反应,其中发生排痰障碍情况者1例、发生口干情况者1例、发生明显腹胀者1例、发生鼻面部压伤者1例,发生率为4/38(10.53%),此结果说明,无创正压通气治疗安全性较高。对照组抗生素使用时间明显长于研究组,两组对照,差异明显(P<0.05),说明研究组使用治疗方案更为理想,可降低抗生素使用时间,改善身体机能,降低药物抵抗性。结论 在COPD急性加重合并重度Ⅱ型呼吸衰竭治疗中,无创正压通气治疗方案实施效果优异,此方案可改善病人住院时间与血气指标水平,此方案值得临床普及与应用。 展开更多
关键词 无创正压通气 copd 呼吸衰竭
下载PDF
改良俯卧位通气对急性呼吸窘迫综合征患者呼吸功能及预后的影响 被引量:2
16
作者 白奎 郭凤杰 秦国泉 《河南医学研究》 CAS 2024年第3期451-455,共5页
目的 探究改良俯卧位通气对急性呼吸窘迫综合征(ARDS)患者血流动力学、呼吸动力学及预后的影响。方法 前瞻性选取河南大学第一附属医院2020年3月至2022年6月收治的98例ARDS患者作为研究对象,通过随机数字表法分为A、B组。通过随机及前... 目的 探究改良俯卧位通气对急性呼吸窘迫综合征(ARDS)患者血流动力学、呼吸动力学及预后的影响。方法 前瞻性选取河南大学第一附属医院2020年3月至2022年6月收治的98例ARDS患者作为研究对象,通过随机数字表法分为A、B组。通过随机及前瞻性平行对照临床研究,评价不同通气方式在ARDS患者中的作用,其中A组52例接受改良式俯卧位通气,B组46例接受传统俯卧位通气。对比两组患者干预前、干预后(俯卧位通气4 h后)血流动力学[心率(HR)、平均动脉压、中心静脉压]、呼吸动力学指标[气道阻力、静态肺顺应性(Cst)]、氧合指数及腹腔压力的变化。比较两组患者不良事件发生情况,对所有患者进行3个月随访,比较两组患者病死率情况。结果 (1)A组机械通气时间低于B组,撤机成功率高于B组(P<0.05);(2)干预后,两组患者HR均较干预前上升,干预前后差值具有统计学意义(P<0.05);(3)干预后,两组Cst水平均较干预前上升且A组高于B组,干预前后差值具有统计学意义(P<0.05);(4)干预后,两组腹腔压力均较治疗前上升且A组低于B组,干预前后差值具有统计学意义(P<0.05);(5)A组不良事件总发生率[7.69%(4/52)]低于B组[23.91%(11/46)](P<0.05);(6)随访3个月结果显示,A组病死率[23.08%(12/52)]低于B组[43.48%(20/46)](P<0.05)。结论 改良俯卧位通气对ARDS血流动力学、呼吸动力学及相关指标均有显著的改善效果,不良事件的发生率较低且预后状况良好,值得临床参考借鉴。 展开更多
关键词 改良俯卧位通气 急性呼吸窘迫综合征 静态肺顺应性 氧合指数 腹腔压力 预后
下载PDF
不同角度俯卧位通气在急性呼吸窘迫综合征患者中的应用效果
17
作者 梁艳东 何伟枫 +2 位作者 刘秋江 黎燕红 庾佳燕 《国际医药卫生导报》 2024年第12期2063-2067,共5页
目的评估不同角度俯卧位通气在急性呼吸窘迫综合征(ARDS)患者中的应用效果。方法本研究为一项前瞻性、随机、对照临床试验,纳入2021年7月至2023年6月广东省第二中医院重症医学科(ICU)收治的ARDS患者共96例,随机分为A组(0°俯卧位通... 目的评估不同角度俯卧位通气在急性呼吸窘迫综合征(ARDS)患者中的应用效果。方法本研究为一项前瞻性、随机、对照临床试验,纳入2021年7月至2023年6月广东省第二中医院重症医学科(ICU)收治的ARDS患者共96例,随机分为A组(0°俯卧位通气)、B组(30°俯卧位通气)、C组(45°俯卧位通气),每组32例。A组男19例,女13例;年龄(50.25±11.31)岁;体重指数(BMI)(23.42±3.16)kg/m^(2)。B组男17例,女15例;年龄(51.93±12.48)岁;BMI(22.72±4.15)kg/m^(2)。C组男20例,女12例;年龄(52.39±12.82)岁;BMI(24.76±4.31)kg/m^(2)。观察时间为5 d。A组患者每天持续0°俯卧位通气16 h,每2 h将其托起一次防止压力性损伤。B组:维持0°俯卧位2 h后,使用30°翻身垫将患者身体向左倾斜30°,维持2 h;然后向右倾斜30°,同样维持2 h;最后恢复至0°俯卧位,如此循环,直至完成16 h俯卧位通气。C组:维持0°俯卧位2 h后,使用45°翻身垫将患者身体向左倾斜45°,维持2 h;然后向右倾斜45°,同样维持2 h;最后恢复至0°俯卧位,如此循环,直至完成16 h俯卧位通气。比较3组氧合指标[氧合指数(PaO_(2)/FiO_(2))、动脉血氧饱和度(SaO_(2))、动脉血氧分压(PaO_(2))、动脉血二氧化碳分压(PaCO_(2))]、血流动力学指标[心率(HR)、平均动脉压(MAP)、中心静脉压(CVP)]、Murray肺损伤评分(MLIS)、急性生理学及慢性健康状况评价Ⅱ(APACHEⅡ)评分、多器官功能障碍综合征(MODS)评分的变化,观察压力性损伤发生率。采用单因素方差分析、LSD法、配对t检验、χ^(2)检验。结果俯卧位通气5 d后,3组PaO_(2)/FiO_(2)、SaO_(2)、PaO_(2)、PaCO_(2)均较通气前改善,且A组、B组改善幅度均优于C组(均P<0.05);俯卧位通气前和通气5 d后,3组HR、MAP、CVP差异均无统计学意义(均P>0.05);俯卧位通气5 d后,3组MLIS、APACHEⅡ、MODS评分均较通气前降低,且A组、B组均低于C组[(1.72±0.37)分比(1.54±0.16)分比(1.89±0.26)分、(11.02±2.69)分比(11.01±2.01)分比(12.87±2.06)分、(5.64±0.37)分比(5.34±0.67)分比(6.19±0.43)分](均P<0.05);B组和C组压力性损伤发生率低于A组[15.63%(5/32)比18.75%(6/32)比40.63%(13/32)](P<0.05)。结论不同角度俯卧位通气均可以改善ARDS患者氧合和减轻病情,其中30°俯卧位通气改善最明显,并且可以降低压力性损伤发生率。 展开更多
关键词 急性呼吸窘迫综合征 俯卧位通气 不同角度 氧合指数 血流动力学 压力性损伤
下载PDF
经鼻高流量湿化治疗仪治疗慢阻肺急性加重期伴呼吸性酸中毒患者的效果
18
作者 赵红侠 董伟 +2 位作者 杨美艳 庞宇 李凌维 《中外医学研究》 2024年第14期62-66,共5页
目的:分析经鼻高流量湿化治疗仪应用于慢阻肺急性加重期伴呼吸性酸中毒的治疗效果,探讨其对患者血气指标及肺功能的影响。方法:回顾性分析2022年1月—2023年10月在北京市昌平区医院呼吸与危重症学科治疗的100例慢阻肺急性加重伴呼吸性... 目的:分析经鼻高流量湿化治疗仪应用于慢阻肺急性加重期伴呼吸性酸中毒的治疗效果,探讨其对患者血气指标及肺功能的影响。方法:回顾性分析2022年1月—2023年10月在北京市昌平区医院呼吸与危重症学科治疗的100例慢阻肺急性加重伴呼吸性酸中毒患者的临床资料。根据治疗方式的不同分为两组,各50例。观察组接受经鼻高流量湿化氧疗,对照组接受无创正压通气治疗。比较两组的血气指标、肺功能指标、治疗效果及不良反应发生情况。结果:观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。治疗前,两组血气指标、肺功能指标比较,差异无统计学意义(P>0.05);治疗后,两组pH值、氧分压(PaO_(2))、氧合指数(OI)均高于治疗前,二氧化碳分压(PaCO_(2))低于治疗前,且观察组pH值、PaO_(2)、OI高于对照组,PaCO_(2)低于对照组,差异有统计学意义(P<0.05)。治疗后,两组第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、呼气峰流速值(PEF)、第1秒用力呼气容积/用力肺活量(FEV_(1)/FVC%)均高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05)。两组不良反应总发生率比较,差异无统计学意义(P>0.05)。结论:经鼻高流量湿化氧疗、无创正压通气治疗都是慢阻肺急性加重期伴呼吸性酸中毒辅助通气的有效方法,而经鼻高流量湿化氧疗可有效提高治疗效果,改善患者血气指标及肺功能,不良反应少,安全性更高。 展开更多
关键词 慢阻肺急性加重期伴呼吸性酸中毒 经鼻高流量湿化氧疗 无创正压通气 动脉血气指标 肺功能
下载PDF
Effects of different levels of end-expiratory positive pressure on lung recruitment and protection in patients with acute respiratory distress syndrome 被引量:3
19
作者 GUO Feng-mei DING Jing-jing SU Xin, XU Hui-ying SHI Yi 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第22期2218-2223,共6页
Background It is still controversial as to the implementation of higher positive end-expiratory pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). This study was conducted to compare the ... Background It is still controversial as to the implementation of higher positive end-expiratory pressure (PEEP) in patients with acute respiratory distress syndrome (ARDS). This study was conducted to compare the lower and higher PEEP in patients with ARDS ventilated with low tidal volume, to investigate the relationship between the recruited lung volume by higher PEEP and relevant independent variables and to provide a bedside estimate of the percentage of potentially recruitable lung by higher PEEP. Methods Twenty-four patients with ARDS were studied. A lung recruiting maneuver was performed, then each patient was ventilated with PEEP of 8 cmH20 for 4 hours and subsequently with PEEP of 16 cmH20 for 4 hours. At the end of each PEEP level period, gas exchange, hemodynamic data, lung mechanics, stress index "b" of the dynamic pressure-time curve, intrinsic PEEP and recruited volume by PEEP were measured. Results Fourteen patients were recruiters whose alveolar recruited volumes induced by PEEP 16 cmH20 were (425_+65) ml and 10 patients were non-recruiters. Compared with the PEEP 8 cmH20 period, after the application of the PEEP 16 cmH20, the PaO2/FiO2 ratio and static lung compliance both remained unchanged in non-recruiters, whereas they increased significantly in recruiters. Changes in PaO2/FiO2 and static lung compliance after PEEP increase were independently associated with the alveolar recruitment. Analyzing the relationship between recruiting maneuver (RM)-induced change in end-expiratory lung volume and the alveolar recruitment induced by PEEP, we found a notable correlation. Conclusions The results of this study indicated that the potential for alveolar recruitment might vary among the ARDS population and the higher PEEP levels should be limited to recruiters. Improving in PaO2/FiO2, static lung compliance after PEEP increase and the shape of the pressure-time curve could be helpful for PEEP application. 展开更多
关键词 acute respiratory distress syndrome end-expiratory positive pressure lung recruitment
原文传递
经鼻高流量氧疗对比无创正压通气在急性心力衰竭伴Ⅰ型呼吸衰竭患者中的应用价值 被引量:2
20
作者 武亚梅 王晶 唐娜 《中国心血管病研究》 CAS 2024年第2期131-135,共5页
目的研究经鼻高流量氧疗(high flow nasal cannula oxygen therapy,HFNC)对比无创正压通气(noninvasive positive pressure ventilation,NPPV)在急性心力衰竭(acute heart failure,AHF)伴Ⅰ型呼吸衰竭患者的治疗效果。方法选择2022年1月... 目的研究经鼻高流量氧疗(high flow nasal cannula oxygen therapy,HFNC)对比无创正压通气(noninvasive positive pressure ventilation,NPPV)在急性心力衰竭(acute heart failure,AHF)伴Ⅰ型呼吸衰竭患者的治疗效果。方法选择2022年1月至2022年12月首都医科大学宣武医院急诊科收治的94例AHF伴Ⅰ型呼吸衰竭患者,随机分为观察组48例和对照组46例。两组患者均给予常规扩血管、利尿等治疗,对照组给予NPPV治疗,观察组给予HFNC治疗,分别比较两组患者治疗前、治疗24 h后的呼吸频率、心率、血清N末端B型利钠肽原(NT-proBNP)、动脉氧分压(PaO_(2))和动脉二氧化碳分压(PaCO_(2))的变化情况及2组比较的区别,应用调查问卷评估两组患者治疗舒适度的区别。随访28 d,分别比较两组患者治疗后误吸、胃胀气等并发症发生率、气管插管率及病死率。结果观察组与对照组治疗后的呼吸频率、心率和NT-proBNP较前明显降低(P均<0.05),PaO_(2)较前升高(P均<0.05),PaCO_(2)较前升高(P<0.05),但仍在正常范围内;观察组治疗后呼吸频率是(23.77±2.36)次/min、心率为(89.17±5.80)次/min、NT-proBNP为[13631.00(9997.25,16328.00)]pg/ml、PaO_(2)为(66.87±2.78)mmHg和PaCO_(2)为(37.06±2.56)mmHg,与对照组的(23.33±2.81)次/min、(87.69±5.02)次/min、[12517.00(9836.75,17742.00)]pg/ml、(67.74±2.67)mmHg和(37.07±1.93)mm Hg比较无统计学差别(均P>0.05);调查问卷显示,观察组舒适度评分大于对照组[(3.35±0.69)分比(2.76±0.77)分,P=0.001],并发症发生率小于对照组(10.41%比28.26%,P=0.028),两组患者气管插管率(12.50%比10.86%)和病死率(10.41%比8.69%)比较无统计学差别(P>0.05)。结论HFNC和NPPV在AHF伴Ⅰ型呼吸衰竭患者中应用均具有较好的治疗效果,但HFNC并发症较较少,患者舒适程度更高。 展开更多
关键词 急性心力衰竭 Ⅰ型呼吸衰竭 经鼻高流量氧疗 无创正压通气
下载PDF
上一页 1 2 36 下一页 到第
使用帮助 返回顶部